[NEJM] Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer

 关闭 求助已关闭
qazwsx2431 发表于 2026-8-6 13:06:22 | 显示全部楼层 |阅读模式
悬赏10积分

期刊:New England Journal of Medicine

文献作者:Matthew D. Galsky; Begona P. Valderrama; Marco Maruzzo; Albert Font; Tudor Ciuleanu; Jonathan Chatzkel; Takuya Koie; Christopher J. Hoimes; Javier Puente; Yousef Zakharia; Eli Rosenbaum; Katharina Boehm; Yohann Loriot; Jens Bedke; Thomas B. Powles; Andrea Necchi; Pawel Wiechno; Carlos Alvarez-Fernández; Tae-Hwan Kim; Niara Oliveira; Thomas W. Flaig; Heidi S. Wirtz; Michael Mihm; Qinlei Huang; Aljosja Rogiers; Blanca Homet Moreno; Alfonso Gómez de Liano

出版日期:2026-7-23

DOI号:10.1056/nejmoa2601486

下载链接:http://www.nejm.org/doi/pdf/10.1056/NEJMoa2601486

文献链接:https://doi.org/10.1056/nejmoa2601486

当前文献来源于 Massachusetts Medical Society


备注信息:
全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

返回列表